Pakistan pharmaceutical market in figures
Retail medicine sales in Pakistan were Rs 1.251 trillion in the 12 months to June 2026 (FY2026), up 14.88%. But the number of packs sold grew only 0.93% (3.80 billion units), so almost all of the growth came from higher prices, not from people buying more medicine.
| Sales | Share | Value growth | Units | Unit growth | |
|---|---|---|---|---|---|
| National (local) companies | Rs 998.54 bn | 79.8% | +16.53% | 3.006 bn | +2.98% |
| Multinational companies | Rs 252.13 bn | 20.2% | +8.76% | 0.794 bn | -6.16% |
New products launched in the period: 989, with sales of Rs 19.18 bn (1.53% of the market).
Leading companies by retail sales
| # | Company | Type | Retail sales | Products listed on MedInfoBase |
|---|---|---|---|---|
| 1 | Getz Pharma | National | Rs 85.27 bn | 282 |
| 2 | Abbott | Multinational | Rs 70.08 bn | 69 |
| 3 | Sami Pharmaceuticals | National | Rs 69.23 bn | 188 |
| 4 | GSK | Multinational | Rs 64.83 bn | 104 |
| 5 | Martin Dow | National | Rs 52.00 bn | 237 |
| 6 | Hilton Pharma | National | Rs 46.60 bn | 262 |
| 7 | High-Q | National | Rs 43.00 bn | 211 |
| 8 | Haleon | Multinational | Rs 38.64 bn | 15 |
| 9 | CCL Pharmaceuticals | National | Rs 32.22 bn | 249 |
| 10 | PharmEvo | National | Rs 24.66 bn | 181 |
| 11 | Ferozsons | National | Rs 20.98 bn | 86 |
Source: ProPakistani, 1 October 2026, quoting data compiled by the pharmaceutical industry and DRAP. MedInfoBase reports these published figures as they were stated and has not audited them.
How MedInfoBase is building its own market data
MedInfoBase already lists every official DRAP price. We are adding measured data step by step, and each kind will always be labelled for what it is: what people look up most (search interest), government purchase rates from published rate contracts, and later a panel of pharmacies sharing anonymous monthly sales counts.